Publications
495 publications
Funding
20 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- PIU19AI181977-03
- PIR01HL163857-04Premature aging disorders, metabolites, and atherosclerosisNHLBI · 2022–2027 · via NIH RePORTER
- PIR01HL157790-04Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chipNHLBI · 2021–2026 · via NIH RePORTER
Completed grants (17)
- PIR01HL148338-04Reversal of Heart Failure: Role of Vascular RecoveryNHLBI · 2020–2024 · via NIH RePORTER
- PIR01HL149303-04Pathological flow-induced endothelial damage and plaque erosionNHLBI · 2019–2023 · via NIH RePORTER
- PIUM1HL113456-01Cell Characterization and Imaging for Regenerative Therapies in Ischemic DiseasesNHLBI · 2012–2019 · via NIH RePORTER
- PIU01HL100397-07Basic and Translational Research iPSC-based hematologic and vascular therapiesNHLBI · 2009–2017 · via NIH RePORTER
- PIR01EY020609-04The Role of the Nicotinic Cholinergic Pathway in Retinopathy of PrematurityNEI · 2011–2015 · via NIH RePORTER
- PIK12HL087746-04Stanford Career Development in Vascular MedicineNHLBI · 2007–2013 · via NIH RePORTER
- PIRC2HL103400-02NCE-based strategy for nuclear reprogramming and regenerative medicineNHLBI · 2009–2011 · via NIH RePORTER
- PIR01CA098303-04Signal-transduction of Endothelial nAChR in AngiogenesisNCI · 2005–2010 · via NIH RePORTER
- PIT32HL007708-15Stanford Vascular Biology and Medicine Training GrantNHLBI · 1992–2009 · via NIH RePORTER
- PIR03HL096238-01Translational research and education in cell therapies for vascular regenerationNHLBI · 2008–2009 · via NIH RePORTER
- PIR21HL085743-02ADMA: An endogenous inhibitor of ESC differentiation and EC regenerationNHLBI · 2006–2009 · via NIH RePORTER
- MPIM01RR000070-45THERAPEUTIC MANIPULATION OF THE NOS PATHWAY IN PERIPHERAL ARTERIAL DISEASENCRR · 2003–2007 · via NIH RePORTER
- PIR01HL063685-05MANIPULATION OF THE NOS PATHWAY IN ARTERIAL DISEASENHLBI · 2000–2006 · via NIH RePORTER